Lee's Pharmaceutical Holdings Limited (GEM) Stock: 8221; Website: www.leespharm.com) today announced that the Group has successfully completed the enrollment of patients for a clinical trial on Horus®s (Coronary Stent with delivery system), following the completion of clinical study on evaluating the effects of Challenger® PTCA Balloon Catheter for patients with coronary heart disease.